【 文献重点摘要 】
 

Objective: To explore factors important to patients considering medical antiaging treatments.

Design: Ten-minute online survey using a global opinion panel.

Setting: Survey of existing and prospective patients cosponsored by the American Society for Dermatologic Surgery and Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC.

Participants: 383 women aged 35 to 69 years (mean, 52 years; 91% Caucasian) with an annual household income of at least $50,000, who were considering undergoing medical antiaging treatments within the next two years (“medical antiaging treatment considerers”). Of these, 100 had used an injectable product such as dermal fillers, collagen replacers, or muscle relaxants in the past two years (“injectable users”); a subset of 64 had specifically used an injectable dermal filler or collagen replacer in the past two years (“filler users”).

Measurements: Maximum difference analysis of factors most important to respondents when considering medical antiaging treatments, safety, and potential for side effects.

Results: Medical antiaging treatment considerers, injectable users, and filler users all identified physician training and expertise as the most important factor (93–95% of respondents); other key factors included duration of effect, cost, how the product works, and recommendation by the physician. In paired comparisons, women were more interested in results that last a long time versus immediate results (89–91% of respondents), and gradual results that last for two years versus immediate results that last for six months (85–89% of respondents).

Conclusion: Physician experience and training is very important to patients who are considering medical antiaging treatments, and should therefore be addressed during the counseling of prospective patients.

目的：探讨影响患者考虑药物抗衰老治疗的重要因素。

设计：使用全球意见小组进行10分钟的在线调查。

单位：由美国皮肤病外科学会和赛诺菲-安万特美国有限责任公司旗下的Dermik实验室共同发起的现有和潜在患者调查。

参与者：383名年龄在35岁到69岁(平均52岁，91%是高加索人)、家庭年收入至少5万美元的女性，她们正在考虑在未来两年内接受医学抗衰老治疗(“医学抗衰老治疗顾问者”)。在这些人中，有100人在过去两年中使用了可注射产品，如真皮填充物、胶原替代物或肌肉松弛剂(“可注射使用者”)；64人中有64人在过去两年中专门使用了可注射真皮填充物或胶原替代物(“填充物使用者”)。

测量：在考虑药物抗衰老治疗、安全性和潜在副作用时，对受访者最重要的因素进行最大差异分析。

结果：医疗抗衰老治疗顾问者、注射剂使用者和填充剂使用者都认为医生的培训和专业知识是最重要的因素(93-95%的受访者)，其他关键因素包括有效期、成本、产品的作用方式和医生的推荐。在配对比较中，女性对持续时间较长的结果更感兴趣(89-91%的受访者)，对持续两年的渐进结果和持续六个月的即时结果(85-89%的受访者)更感兴趣。

结论：医生的经验和培训对于正在考虑药物抗衰老治疗的患者非常重要，因此在对未来患者进行咨询时应该考虑到这一点。